Premium
Non‐steroidal anti‐inflammatory drugs selectively inhibit cytokine production by NK cells and γδ T cells
Author(s) -
Inaoka Miyuki,
Kimishima Momoko,
Takahashi Ryo,
Shiohara Tetsuo
Publication year - 2006
Publication title -
experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.108
H-Index - 96
eISSN - 1600-0625
pISSN - 0906-6705
DOI - 10.1111/j.1600-0625.2006.00505.x
Subject(s) - cytokine , immune system , tumor necrosis factor alpha , immunology , innate immune system , population , interferon , inflammation , biology , medicine , pharmacology , environmental health
Non‐steroidal anti‐inflammatory drugs (NSAIDs) are known to be risk factors for a systemic inflammatory syndrome in viral infections. Innate immune cells are likely to represent the preferential targets for the deleterious effects of NSAIDs in patients with viral infections. We therefore examined whether various classes of NSAIDs could selectively inhibit cytokine production by innate immune cells. NSAIDs selectively inhibited interferon (IFN)‐ γ and tumor necrosis factor (TNF)‐ α production by natural killer (NK) and γδ T cells with each NSAID displaying its own unique pattern of inhibition, while sparing that by acquired immune cells. These inhibitions were independent on cyclooxygenase inhibition. These NSAIDs directly inhibited the cytokine production by the purified γδ T‐cell population without involving other cell populations. The selective inhibition of the early generation of IFN‐ γ and TNF‐ α from NK and γδ T cells by NSAIDs may serve to drive the subsequent acquired immune responses towards a Th2 phenotype, leading to the aggravation of allergic symptoms. Our results provide a mechanism to explain the deleterious effects of NSAIDs on clinical symptoms of viral infections and allergic diseases and suggest more targeted use depending on the type of disease.